VACCINEX, INC. (VCNX)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue Quarterly

0 300K 600K 900K Q1 '18: 206K Q2 '18: 126K Q3 '18: 198K Q4 '18: 194K Q1 '19: 94K Q2 '19: 25K Q3 '19: 404K Q4 '19: 0 Q3 '20: 625K Q4 '20: 0 Q1 '21: 850K Q2 '21: 0 Q3 '21: 50K Q4 '21: 0 Q3 '22: 50K Q4 '22: 225K Q1 '23: 550K Q2 '23: 0 Q3 '23: 20K Q4 '23: 0 Q1 '24: 104K Q2 '24: 232K Q3 '24: 52K Q4 '24: 213K Q3 '18 Q2 '19 Q3 '20 Q2 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24

Gross Profit Quarterly

-250K 0 250K 500K 750K Q1 '18: -34K Q2 '18: -120K Q3 '18: -48K Q4 '18: -107K Q1 '19: -81K Q2 '19: 9K Q3 '19: 396K Q4 '19: 0 Q3 '20: 623K Q4 '20: 0 Q2 '18 Q4 '18 Q2 '19 Q4 '19 Q4 '20

Revenue minus cost of sales. This filer tags no gross profit of its own..

Operating Income Quarterly

-10.5M -7M -3.5M 0 3.5M 7M 10.5M Q1 '17: -4.9M Q2 '17: -4.7M Q3 '17: -5.3M Q4 '17: -6.2M Q1 '18: -5.7M Q2 '18: -6.6M Q3 '18: -6.5M Q4 '18: -8.6M Q1 '19: -9.1M Q2 '19: -8.9M Q3 '19: -7.7M Q4 '19: -6.3M Q1 '20: -7.2M Q2 '20: -6.5M Q3 '20: -8.6M Q4 '20: -6.1M Q1 '21: -6.2M Q2 '21: -5.7M Q3 '21: -5.1M Q4 '21: -5.5M Q1 '22: -4.6M Q2 '22: -5.4M Q3 '22: -4.8M Q4 '22: -5.1M Q1 '23: -5M Q2 '23: -7.1M Q3 '23: -5.8M Q4 '23: -5M Q1 '24: -5.1M Q2 '24: -5.7M Q3 '24: -4.6M Q4 '24: -3.4M Q4 '17 Q4 '18 Q4 '19 Q4 '20 Q4 '21 Q4 '22 Q4 '23 Q4 '24

Net Income Quarterly

-10.5M -7M -3.5M 0 3.5M 7M 10.5M Q1 '17: -5.7M Q2 '17: -4.9M Q3 '17: -5.5M Q4 '17: -2.6M Q1 '18: -7.9M Q2 '18: -6.6M Q3 '18: -6.6M Q4 '18: -8.4M Q1 '19: -9.1M Q2 '19: -8.8M Q3 '19: -7.6M Q4 '19: -6.3M Q1 '20: -7.1M Q2 '20: -6.5M Q3 '20: -8.8M Q4 '20: -6.4M Q1 '21: -6.6M Q2 '21: -6M Q3 '21: -5.2M Q4 '21: -4.6M Q1 '22: -4.6M Q2 '22: -5.4M Q3 '22: -4.8M Q4 '22: -5.1M Q1 '23: -5M Q2 '23: -7.1M Q3 '23: -4.9M Q4 '23: -3.3M Q1 '24: -3.9M Q2 '24: -5.6M Q3 '24: -5.7M Q4 '24: -3.4M Q4 '17 Q4 '18 Q4 '19 Q4 '20 Q4 '21 Q4 '22 Q4 '23 Q4 '24

Cost of Revenue Quarterly

0 150K 300K 450K Q1 '18: 240K Q2 '18: 246K Q3 '18: 246K Q4 '18: 301K Q1 '19: 175K Q2 '19: 16K Q3 '19: 8K Q4 '19: 0 Q3 '20: 2K Q4 '20: 0 Q2 '18 Q4 '18 Q2 '19 Q4 '19 Q4 '20

Operating Cash Flow Quarterly

-12M -8M -4M 0 4M 8M 12M Q3 '17: -4.7M Q4 '17: -6.2M Q1 '18: -5.2M Q2 '18: -5.3M Q3 '18: -7.2M Q4 '18: -7.6M Q1 '19: -8.5M Q2 '19: -5.9M Q3 '19: -10.5M Q4 '19: -5.8M Q1 '20: -7.5M Q2 '20: -5.4M Q3 '20: -9.3M Q4 '20: -6.4M Q1 '21: -7.1M Q2 '21: -7M Q3 '21: -6.1M Q4 '21: -5.1M Q1 '22: -5M Q2 '22: -5.3M Q3 '22: -4.1M Q4 '22: -4.6M Q1 '23: -5M Q2 '23: -5.5M Q3 '23: -3.1M Q4 '23: -7.7M Q1 '24: -4.6M Q2 '24: -4.4M Q3 '24: -3.2M Q4 '24: -3.9M Q4 '17 Q4 '18 Q4 '19 Q4 '20 Q4 '21 Q4 '22 Q4 '23 Q4 '24

Free Cash Flow Quarterly

-12M -8M -4M 0 4M 8M 12M Q3 '17: -4.7M Q4 '17: -6.2M Q1 '18: -5.2M Q2 '18: -5.3M Q3 '18: -7.2M Q4 '18: -7.7M Q3 '19: -10.5M Q4 '19: -5.8M Q1 '20: -7.8M Q2 '20: -5.4M Q3 '20: -9.3M Q4 '20: -6.4M Q3 '21: -6.1M Q4 '21: -5.1M Q3 '22: -4.2M Q4 '22: -4.6M Q1 '23: -5.1M Q2 '23: -5.5M Q3 '23: -3.1M Q4 '23: -7.7M Q1 '24: -4.6M Q2 '24: -4.4M Q3 '24: -3.2M Q4 '24: -3.9M Q1 '18 Q4 '18 Q1 '20 Q4 '20 Q3 '22 Q2 '23 Q1 '24 Q4 '24

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 15M 30M 45M Q2 '21: 28.6M Q3 '21: 30.8M Q1 '22: 38.8M Q2 '22: 42.7M Q3 '22: 2.8M Q1 '23: 237.5K Q2 '23: 287.7K Q3 '23: 322.2K Q1 '24: 1.3M Q2 '24: 1.8M Q3 '24: 2M Q2 '21 Q1 '22 Q3 '22 Q2 '23 Q1 '24 Q3 '24

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-180.00 -120.00 -60.00 0.00 60.00 120.00 180.00 Q4 '17: -19.90 Q1 '18: -21.11 Q2 '18: -22.68 Q3 '18: -17.86 Q4 '18: -5.65 Q1 '19: 0.69 Q2 '19: 6.64 Q3 '19: 7.01 Q4 '19: -2.50 Q1 '20: -2.16 Q2 '20: -1.78 Q3 '20: -1.66 Q4 '20: -1.55 Q1 '21: -1.36 Q2 '21: -1.18 Q3 '21: -0.91 Q4 '21: -0.79 Q1 '22: -0.65 Q2 '22: -0.57 Q3 '22: -2.07 Q4 '22: -94.63 Q1 '23: -115.40 Q2 '23: -139.81 Q3 '23: -153.39 Q4 '23: -43.68 Q1 '24: -25.73 Q2 '24: -4.29 Q3 '24: 8.13 Q4 '24: -8.90 Q4 '17 Q4 '18 Q4 '19 Q4 '20 Q4 '21 Q4 '22 Q4 '23 Q4 '24

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.